- Home
- VALN vs CAPL Comparison
VALN vs CAPL Comparison
Compare VALN & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- CAPL
- Stock Information
- Founded
- VALN 2012
- CAPL 1992
- Country
- VALN France
- CAPL United States
- Employees
- VALN N/A
- CAPL N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- CAPL Oil Refining/Marketing
- Sector
- VALN Health Care
- CAPL Energy
- Exchange
- VALN Nasdaq
- CAPL Nasdaq
- Market Cap
- VALN 669.2M
- CAPL 788.6M
- IPO Year
- VALN 2021
- CAPL 2012
- Fundamental
- Price
- VALN $9.11
- CAPL $20.29
- Analyst Decision
- VALN Strong Buy
- CAPL
- Analyst Count
- VALN 3
- CAPL 0
- Target Price
- VALN $15.33
- CAPL N/A
- AVG Volume (30 Days)
- VALN 65.5K
- CAPL 36.3K
- Earning Date
- VALN 08-12-2025
- CAPL 08-06-2025
- Dividend Yield
- VALN N/A
- CAPL 10.34%
- EPS Growth
- VALN N/A
- CAPL 100.77
- EPS
- VALN N/A
- CAPL 1.13
- Revenue
- VALN $201,099,222.00
- CAPL $3,522,840,000.00
- Revenue This Year
- VALN $18.61
- CAPL N/A
- Revenue Next Year
- VALN $25.07
- CAPL N/A
- P/E Ratio
- VALN N/A
- CAPL $18.04
- Revenue Growth
- VALN 21.64
- CAPL N/A
- 52 Week Low
- VALN $3.62
- CAPL $19.05
- 52 Week High
- VALN $9.10
- CAPL $25.73
- Technical
- Relative Strength Index (RSI)
- VALN 80.93
- CAPL 37.36
- Support Level
- VALN $7.15
- CAPL $19.78
- Resistance Level
- VALN $7.82
- CAPL $22.41
- Average True Range (ATR)
- VALN 0.40
- CAPL 0.50
- MACD
- VALN 0.14
- CAPL -0.16
- Stochastic Oscillator
- VALN 99.37
- CAPL 18.82
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.